- Matthias Egger, reader in social medicine and epidemiologya (m.egger@bristol.ac.uk),
- George Davey Smith, professor of clinical epidemiologya
- a Department of Social Medicine, University of Bristol, Bristol BS8 2PR
- Correspondence to: Dr Egger
Introdution
Meta-analysis has received a mixed reception since the outset. Some people have rejected what they see as exercises in “mega-silliness,”1 while the purveyors of a highly distinguished series of meta-analyses of perinatal medical care2 have been dismissed as “an obstetrical Baader-Meinhof gang.”3 To some clinicians objecting to the findings of meta-analyses, “a tool has become a weapon.”4 At the other end of the spectrum, the application of a technique that basically consists of calculating a weighted average has been hailed as “Newtonian,”5 and it has been suggested that meta-analysis has left no place for the narrative review article.6 The truth is likely to lie somewhere between these extreme views.
Summary points
Bias can be introduced in many ways into the process of locating and selecting studies for inclusion in meta-analysis
Studies with significant results are more likely to get published than studies without significant results, leading to publication bias
Among published studies, those with significant results are more likely to get published in English, more likely to be cited, and more likely to be published repeatedly, leading to English language bias, citation bias, and multiple publication bias
In less developed countries, studies with significant results may be more likely to get published in a journal indexed in a literature database, which can introduce database bias
Criteria for including studies in a meta-analysis may be influenced by knowledge of the results of the set of potential studies, leading to inclusion bias
The likely presence or absence of bias should be routinely examined in sensitivity analyses and funnel plots
That meta-analysis holds potential problems can be illustrated by contrasting the conclusions of two meta-analyses comparing low molecular weight heparins and standard heparin in the prevention of thrombosis after surgery.7 8 One group concluded that “low molecular weight …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012